US equities
|
MU
$976.24
▲+5.11%
SNDK
$1,375.15
▲+5.39%
SPCX
$144.44
▼-2.79%
TSLA
$402.94
▼-1.11%
META
$620.14
▼-0.01%
SKHY
$160.03
▲+10.09%
NVDA
$218.81
▲+0.40%
GOOGL
$324.23
▲+1.14%
MU
$976.24
▲+5.11%
SNDK
$1,375.15
▲+5.39%
SPCX
$144.44
▼-2.79%
TSLA
$402.94
▼-1.11%
META
$620.14
▼-0.01%
SKHY
$160.03
▲+10.09%
NVDA
$218.81
▲+0.40%
GOOGL
$324.23
▲+1.14%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about TCR2 Therapeutics Inc/
Recent news which mentions TCR2 Therapeutics Inc/
Adaptimmune to acquire Boston-area cell therapy company TCR² Therapeutics
March 06, 2023
Tags
Insurance
Adrian Rawcliffe
Mergers and Acquisitions
From
Business Journals